Cargando…
Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study
The gut microbiota system plays a vital role in liver diseases. This study aimed to address the diversity of gut microbiota and its correlations with clinical parameters in healthy individuals, chronic liver disease (CLD), and hepatocellular carcinoma (HCC) patients. Fecal specimens of nine healthy...
Autores principales: | Chen, Tianyou, Ding, Rongrong, Chen, Xiaorong, Lu, Yunfei, Shi, Jia, Lü, Ying, Tang, Bozong, Zhang, Wensi, Ye, Chen, Yuan, Min, Yang, Zongguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806631/ https://www.ncbi.nlm.nih.gov/pubmed/34592890 http://dx.doi.org/10.1080/21655979.2021.1982273 |
Ejemplares similares
-
Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization
por: Yang, Zongguo, et al.
Publicado: (2015) -
Utilization of dietary mixed-linkage β-glucans by the Firmicute Blautia producta
por: Singh, Ravindra Pal, et al.
Publicado: (2023) -
Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis
por: Yang, Zongguo, et al.
Publicado: (2016) -
HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus
por: Yang, Zongguo, et al.
Publicado: (2015) -
Add-On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials
por: Yang, Zongguo, et al.
Publicado: (2017)